Intelligent Bio Solutions resolves cybersecurity, software items ahead of planned FDA 510(k) filing in H2 2026

PUBT · 2d ago
Intelligent Bio Solutions resolves cybersecurity, software items ahead of planned FDA 510(k) filing in H2 2026
  • Intelligent Bio Solutions resolved all cybersecurity and software review items for its planned FDA 510(k) filing.
  • 510(k) submission remains on track for calendar H2 2026, supporting a planned entry into the U.S. drug screening market.
  • Penetration-test remediation cleared 100% of medium-risk issues; low-risk items fell to 2 from 11 with a risk-based justification.
  • All 19 software bill of materials vulnerabilities were resolved; independent third-party verification found no remaining issues.
  • Initial 510(k) indication targets codeine detection, positioning the fingerprint-sweat system for broader U.S. use beyond forensic-only settings.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034428), on July 23, 2026, and is solely responsible for the information contained therein.